Zusammenfassung
Die meisten Ärzte lesen mehr oder weniger regelmäßig wissenschaftliche Fachliteratur, um sich über neue Entwicklungen und Erfahrungen in ihrem medizinischen Arbeitsgebiet zu informieren und diese Kenntnisse für die beste und sicherste Behandlung ihrer Patienten zu nutzen. Verständliche, objektive Berichte über Untersuchungsergebnisse, die für medizinische Entscheidungen relevant sind, erhöhen die Behandlungsqualität und kommen den Patienten zugute. In der Realität gibt es jedoch leider viele Artikel, die diesem Ideal nicht entsprechen, weil inadäquate Methoden (Design, Durchführung, Analyse, Interpretation) angewendet oder die Ergebnisse übertrieben dargestellt wurden; dominante Firmeninteressen oder mangelnde Sorgfalt können den Nutzen ebenfalls stark einschränken. Um trotz dieser Hindernisse brauchbare Informationen entnehmen und Zuverlässiges erkennen zu können, helfen gute Methodenkenntnisse. Dieses Kapitel erläutert einige Grundprinzipien und soll den Sinn für das qualitative Beurteilen herzchirurgischer Fachliteratur schärfen. Im Idealfall ist es auch beim Verfassen eines Artikels hilfreich. Es kann und will jedoch kein Lehrbuch über wissenschaftliches Arbeiten ersetzen.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
Literatur
Abraham NS, Young JM, Solomon MJ (2006) A systematic review of reasons for nonentry of eligible patients into surgical randomized controlled trials. Surgery 139:469–483
Abraham NS, Byrne CJ, Young JM, Solomon MJ (2010) Meta-analysis of well-designed nonrandomized comparative studies of surgical procedures is as good as randomized controlled trials. J Clin Epidemiol 63:238–425
Annesley TM (2010a) The title says it all. Clin Chem 56:357–600
Annesley TM (2010b) Who, what, when, where, how, and why: the ingredients in the recipe for a succesful methods section. Clin Chem 56:897–901
Annesley TM (2010c) The discussion section: your closing argument. Clin Chem 56:1671–1674
Annesley TM (2010d) Bring your best to the table. Clin Chem 56:1528–1534
Annesley TM (2010e) Put your best figure forward: line graphs and scattergrams. Clin Chem 56:1229–1233
Annesley TM (2011) Giving credit: citations and references. Clin Chem 57:14–17
Antunes MJ (2008) Guidelines in real life. Why are they not always enforced? Eur J Cardiothorac Surg 34:935–936
Bastian H (2014) A stronger post-publication culture is needed for better science. PLoS Med 11:e1001772
Bekelman JE, Li Y, Gross CP (2003) Scope and impact of financial conflicts of interest in biomedical research: a systematic review. JAMA 289:454–465
Benjamin DJ et al (2017) Redefine statistical significance. Nat Hum Behav 2(1). https://doi.org/10.1038/s41562-017-0189-z
Benson K, Hartz AJ (2000) A comparison of observational studies and randomized, controlled trials. N Engl J Med 342:1878–1886
Benstoem C, Moza A, Autschbach R, Stoppe C, Goetzenich A (2015) Evaluating outcomes used in cardiothoracic interventional research: a systematic review of reviews to develop a core outcome set. PLoS One 10:e0122204
Black N (1996) Why we need observational studies to evaluate the effectiveness of health care. BMJ 312:1215–1218
Black N (1999) Evidence-based surgery: a passing fad? World J Surg 23:789–793
Braga LH, Farrokhyar F, Bhandari M (2012) Confounding: what it is and how do we deal with it? J Can Chir 55:132–138
Brennan P, Croft P (1994) Interpreting the results of observational research: chance is not such a fine thing. BMJ 309:727–730
van den Broek MA, van Dam RM, Malagó M, Dejong CH, van Breukelen GJ, Olde Damink SW (2009) Feasibility of randomized controlled trials in liver surgery using surgery-related mortality or morbidity as endpoint. Br J Surg 96:1005–1014
Chalmers I, Glasziou P (2009) Avoidable waste in the production and reporting of research evidence. Lancet 374:86–89
Chan AW, Altman DG (2005) Epidemiology and reporting of randomised trials published in PubMed jounals. Lancet 365:1159–1162
Chan AW, Hróbjartsson A, Haahr MT, Gøtzsche PC, Altman DG (2004) Empirical evidence for selective reporting of outcomes in randomized trials: comparison of protocols to published articles. JAMA 291:2457–2465
Chang L, Dhruva SS, Chu J, Bero LA, Redberg RF (2015) Selective reporting in trials of high risk cardiovascular devices: cross sectional comparison between premarket approval summaries and published reports. Br Med J 350:h2613
Chen CE, Dhruva SS, Redberg RF (2012) Inclusion of comparative effectiveness data in high-risk cardiovascular device studies at the time of premarket approval. JAMA 308:1740–1742
Concato J, Shah N, Horwitz RI (2000) Randomized, controlled trials, observational studies, and the hierarchy of research designs. N Engl J Med 342:1887–1892
Cutlip DE, Windecker S, Mehran R, Boam A, Cohen DJ, van Es GA et al (2007) Clinical end points in coronary stent trials: a case for standardized definitions. Circulation 115:2344–2351
Da Costa BR, Gahl B, Jüni P (2014) Tools and techniques – statistics: propensity score techniques. EuroIntervention 10:761–767
Djulbegovic B, Clarke M (2001) Scientific and ethical issues in equivalence trials. JAMA 285:1206–1208
Ebrahim S, Sohani ZN, Montoya L, Agarwal A, Thorlund K, Mills EJ, Ioannidis JP (2014) Reanalyses of randomized clinical trial data. JAMA 312:1024–1032
Feinstein AR (1989) Epidemiologic analyses of causation: the unlearned scientific lessons of randomized trials. J Clin Epidemiol 42:481–489
Fisher DM (1999) Surrogate outcomes: meaningful not! Anesthesiology 90:355–356
Flacco ME, Manzoli L, Boccia S, Capasso L, Aleksovska K, Rosso A et al (2005) Head-to-head randomized trials are mostly industry sponsored and almost always favor the industry sponsor. J Clin Epidemiol 68:811–820
Florence AL (1960) Is thalidomide to blame? Br Med J 2:1954
Fraser AG, Dunstan FD (2010) On the impossibility of being expert. BMJ 341:c6815
Friedman LS, Richter ED (2004) Relationship between conflicts of interest and research results. J Gen Intern Med 19:51–56
Garas G, Ibrahim A, Ashrafian H, Ahmed K, Patel V, Okabayashi K et al (2012) Evidence-based surgery: barriers, solutions, and the role of evidence synthesis. World J Surg 36:1723–1731
Garattini S, Bertele V (2007) Non-inferiority trials are unethical because they disregard patients’ interests. Lancet 370:1875–1877
Glasziou P, Altman DG, Bossuyt P, Boutron I, Clarke M, Julious S et al (2014) Reducing waste from incomplete or unusable reports of biomedical research. Lancet 383:267–276
Goldfarb M, Drudi L, Almohammadi M, Langlois Y, Noiseux N, Perrault L et al (2015) Outcome reporting in cardiac surgery trials: systematic review and critical appraisal. J Am Heart Assoc 4:e002204
Gotzsche PC (2006) Lessons from and cautions about noninferiority and equivalence randomized trials. JAMA 295:1172–1174
Griffith BP, Hattler BG, Hardesty RL, Kormos RL, Pham SM, Bahnson HA (1995) The need for accurate risk-adjusted measures of outcome in surgery. Lessons learned through coronary artery bypass. Ann Surg 222:593–598
Grimes DA, Schulz KF (2002) An overview of clinical research: the lay of the land. Lancet 359:57–61
Grunkemeier GL, Jin R, Eijkemans MJ, Takkenberg JJ (2007) Actual and actuarial probabilities of competing risks: apples and lemons. Ann Thorac Surg 83:1586–1592
Hernán MA, Hernández-Díaz S, Werler MM, Mitchell AA (2002) Causal knowledge as a prerequisite for confounding evaluation: an application to birth defects epidemiology. Am J Epidemiol 155:176–184
Hickey GL, Grant SW, Cosgriff R, Dimarakis I, Pagano D, Kappetein AP, Bridgewater B (2013) Clinical registries: governance, management, analysis and applications. Eur J Cardiothorac Surg 44:605–614
Hickey GL, Dunning J, Seifert B, Sodeck G, Carr MJ, Burger HU, Beyersdorf F (2015) Statistical and data reporting guidelines for the European Journal of Cardiothoracic Surgery and the Interactive Cardiovascular and Throracic Surgery. Eur J Cardiothorac Surg 48:180–193
Huebner M, Vach W, le Cessie S (2016) A systematic approach to initial data analysisis good research practice. J Thorac Cardiovasc Surg 151:25–27
Ioannides JP (2005a) Why most published research findings are false. PLoS Med 8:e124
Ioannides JP (2005b) Contradicted and initially stronger effects in highly cited clinical research. JAMA 294:218–228
Ioannidis JP (2014) How to make more published research true. PLoS Med 11:e1001747
Juni P, Altman DG, Egger M (2001) Systematic reviews in health care: assessing the quality of controlled clinical trials. BMJ 323:42–46
Jüni P, Nartey L, Reichenbach S, Dieppe PA, Sterchi R, Egger M (2004) Risk of cardiovascular events and rofecoxib: cumulative meta-analysis. Lancet 364:2021–2029
Kjaergard LL, Als-Nielsen B (2002) Association between competing interests and authors’ conclusions: epidemiological study of randomised clinical trials published in the BMJ. BMJ 325:249
Lassen K, Hϕye A, Myrmel T (2012) Randomised trials in surgery: the burden of evidence. Rev Recent Clin Trials 7:244–248
Lundh A, Sismondo S, Lexchin J, Busuioc OA, Bero L (2012) Industry sponsorship and research outcome. Cochrane Database Syst Rev 12:MR000033
Marshall BJ, Warren JR (1984) Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet 1:1311–1315
McCulloch P, Taylor I, Sasako M, Lovett B, Griffin D (2002) Randomised trials in surgery: problems and possible solutions. BMJ 324:1448–1451
McKenna UG, Meadows JA, Brewer NS, Wilson WR, Perrault J (1980) Toxic shock syndrome, a newly recognized disease entity. Report of 11 cases. Mayo Clin Proc 55:663–672
Meakins JL (2002) Innovation in surgery: the rules of evidence. Am J Surg 183:399–405
Myles PS (2014) Meaningful outcome measures in cardiac surgery. J Extra Corpor Technol 46:23–27
Naylor CD, Guyatt GH (1996) Users’ guides to the medical literature. X. How to use an article reporting variations in the outcomes of health services. The Evidence-Based Medicine Working Group. JAMA 275:554–558
Nuesch E, Reichenbach S, Trelle S, Rutjes AW, Liewald K, Sterchi R et al (2009) The importance of allocation concealment and patient blinding in osteoarthritis trials: a meta-epidemiologic study. Arthritis Rheum 61:1633–1641
Piaggio G, Elbourne DR, Pocock SJ, Evans SJ, Altman DG, CONSORT Group (2012) Reporting of noninferiority and equivalence randomized trials: extension of the CONSORT 2010 statement. JAMA 308:2594–2604
Pocock SJ, Clayton TC, Altman DG (2002) Survival plots of time-to-event outcomes in clinical trials: good practice and pitfalls. Lancet 359:1686–1689
Pollock AV (1989) The rise and fall of the random controlled trial in surgery. Theor Surg 4:163–170
Porter ME, Larsson S, Lee TH (2016) Standardizing patient outcome measurement. N Engl J Med 374:504–506
Rahimi K, Malhotra A, Banning A, Jenkinson C (2010) Outcome selection and role of patient reported outcomes in contemporary cardiovascular trials: systematic review. BMJ 341:c5707
Ramsay CR, Grant AM, Wallace SA, Garthwaite PH, Monk AF, Russell IT (2001) Statistical assessment of the learning curves of health technologies. Health Technol Assess 5:1–79
Rising K, Bacchetti P, Bero L (2008) Reporting bias in drug trials submitted to the Food and Drug Administration: review of publication and presentation. PLoS Med 5:e217
Rosenbaum L (2003) Understanding bias-the case for careful study. NEJM 372:1959–1963
Sackett DL, Richardson WS, Rosenberg W, Haynes RB (1997) Evidence-based medicine: how to practice and teach EBM. Churchill Livingtone, New York
Sacks H, Chalmers TC, Smith H Jr (1982) Randomized versus historical controls for clinical trials. Am J Med 72:233–240
Schulz KF, Chalmers I, Hayes RJ, Altman DG (1995) Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA 273:408–412
Shroyer AL, McDonald GO, Wagner BD, Johnson R, Schade LM, Bell MR, Grover FL (2008) Improving quality of care in cardiac surgery: evaluating risk factors, processes of care, structures of care, and outcomes. Semin Cardiothorac Vasc Anesth 12:140–152
Solomon MJ, McLeod RS (1995) Should we be performing more randomized controlled trials evaluating surgical operations? Surgery 118:459–467
Solomon MJ, Laxamana A, Devore L, McLeod RS (1994) Randomized controlled trials in surgery. Surgery 115:707–712
Steere AC, Malawista SE, Snydman DR, Shope RE, Andiman WA, Ross MR, Steele FM (1977) Lyme arthritis: an epidemic of oligoarticular arthritis in children and adults in three connecticut communities. Arthritis Rheum 20:7–17
Steinberg SM, Popa MR, Michalek JA, Bethel MJ, Ellison EC (2008) Comparison of risk adjustment methodologies in surgical quality improvement. Surgery 144:662–667
Thygesen K, Alpert JS, Jaffe AS, Simoons ML, Chaitman BR, White HD, Joint ESC/ACCF/AHA/WHF Task Force for the Universal Definition of Myocardial Infarction (2012) Third universal definition of myocardial infarction. Circulation 126:2020–2035
Van Rij AM, McDonald JR, Pettigrew RA, Putterill MJ, Reddy CK, Wright JJ (1995) CUSUM as an aid to early assessment of the surgical trainee. Br J Surg 82:1500–1503
Vandenbroucke JP, von Elm E, Altman DG, Gøtzsche PC, Mulrow CD, Pocock SJ, STROBE Initiative et al (2014) Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration. Int J Surg 12:1500–1524
Vittinghoff E, McCulloch CE (2007) Relaxing the rule of ten events per variable in logistic and Cox regression. Am J Epidemiol 165:710–718
Von Allmen RS, Weiss S, Tevaearai HT, Kuemmerli C, Tinner C, Carrel TP et al (2015) Completeness of follow-up determines validity of study findings: results of a prospective repeated measures cohort study. PLoS One 10:e0140817
Vranckx P, Cutlip DE, Mehran R, Kint PP, Silber S, Windecker S, Serruys PW (2010) Myocardial infarction adjudication in contemporary all-comer stent trials: balancing sensitivity and specificity. Addendum to the historical MI definitions used in stent studies. EuroIntervention 5:871–874
Wood L, Egger M, Gluud LL, Schulz KF, Juni P, Altman DG (2008) Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study. BMJ 336:601–605
Yordanov Y, Dechartres A, Porcher R, Boutron I, Altman DG, Ravaud P (2015) Avoidable waste of research related to inadequate methods in clinical trials. BMJ 350:h809
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer-Verlag GmbH Austria, ein Teil von Springer Nature
About this chapter
Cite this chapter
Gahl, B., Stanger, O. (2020). Wissenschaftliche Grundlagen der herzchirurgischen Fachliteratur. In: Stanger, O. (eds) Kompendium der modernen Herzchirurgie beim Erwachsenen. Springer, Vienna. https://doi.org/10.1007/978-3-7091-0451-4_20
Download citation
DOI: https://doi.org/10.1007/978-3-7091-0451-4_20
Published:
Publisher Name: Springer, Vienna
Print ISBN: 978-3-7091-0450-7
Online ISBN: 978-3-7091-0451-4
eBook Packages: Medicine (German Language)